CYP 3.85% 25.0¢ cynata therapeutics limited

2020 - A Year Full Of Potentials, page-71

  1. 3,880 Posts.
    lightbulb Created with Sketch. 1318

    "It is worth noting the Cymerus process has a number of key advantages including being only platform in the world able to produce commercial quantities of MSCs from a single source."

    Yes well we all know that this statement is complete BS. We expect it from HC posters, not from management.
    JCR have been selling their product Temcell for years and yes they may have needed a couple of cell donations over the years however do you really think that this is not a commercial business.

    So if a very misleading statement like the above flows so easily from his mouth , what can investors believe?

    Good luck all, it appears that we all will need it tomorrow.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.010(3.85%)
Mkt cap ! $44.90M
Open High Low Value Volume
26.0¢ 26.5¢ 25.0¢ $5.869K 22.42K

Buyers (Bids)

No. Vol. Price($)
1 29342 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 30000 1
View Market Depth
Last trade - 15.47pm 11/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.